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Objectives: The current prevalence of Diabetes Mellitus (DM) in Slovakia ranges 
in about 340000 cases. Insulin therapy is realised in the group about 44000 patients, 
including about 21000 men and 23000 women in the patients older than 19 years. 
Till now in the Czech Republic and in the Slovak Republic there was not realised the 
study oriented on the quality of life (QolL) in relation to young people with DM type 
I, treated by insulin pens or insulin pumps. MethOds: 102 patients with type 1 dia-
betes mellitus aged from 18 to 35 attending diabetes centres and clinics in Brno and 
its surroundings were studied. The method of quantitative research was used to col-
lect the data obtained by standardized questionnaire ADDQoL and DTSQs with the 
confirmed copyright. Results: The general value of QoL was 5.65 on the numeric 
scale from 0 to 10 (0 for the worst results, 10 for the best results). The positive sta-
tistical significance with “p” lesser than 0.05 was find out comparing insulin pump 
vs insulin pen: hobby and free time physical activities, family life, recommendation 
treatment by pump, and satisfaction with the form of treatment and continuing 
of the treatment. The evaluation of these categories has no statistical significance: 
too high level of glucose in the blood, too small level of glucose in the blood, the 
adaptation to the treatment, and the understanding to the illness. cOnclusiOns: 
Statistical evaluation of the hypotheses confirmed a better quality of life in patients 
with insulin pump. On the contrary, the difference in perception of the quality of life 
between the sexes was not proved. Our research confirmed that the insulin pump 
is a modern way of compensation and has a positive impact on the quality of life 
in young patients with diabetes.
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Objectives: The “rule of halves” (ROH) applies in most common chronic disorders 
and suggests that half of the patients are undiagnosed, half of those diagnosed are 
not treated, and half of those treated are not controlled. The aim of the present 
study was to examine whether the ROH is applicable in the case of Diabetes type 2 
in Greece. MethOds: Physicians who monitor patients with type 2 diabetes were 
invited to participate and complete the online version of a purpose-made question-
naire during a specified time period. An invitation was sent to the national associa-
tions of general practitioners (GPs), diabetologists and endocrinologists. The study 
took place between April and May 2014. Fully completed questionnaires were included 
in the analysis. Data analysis was conducted using STATA 9. Results: 176 physicians 
completed the questionnaire of whom 68.7% were men. Mean age was 47.8 years. The 
majority were internists and GPs (38.3% and 32.7%, respectively). Physicians estimated 
that in Greece 62% of those diagnosed with diabetes type 2 receive some kind of treat-
ment (lifestyle or pharmacotherapy). 59.3% of those diagnosed will present at least 
one complication because of the disease. Less than half (43.3%) of those treated are 
controlled and achieve treatment targets (HbA1c≤ 7%). Of those not controlled, 73.3% 
will present at least one complication because of diabetes type 2. cOnclusiOns: 
According to our findings, in Greece more than half of the diagnosed patients with 
diabetes type 2 receive treatment in a regular basis. However, less than half achieve 
treatment targets and manage to stay controlled. Emphasis should be given in self-
management, patient education and policies raising awareness for the early detec-
tion and management of diabetes type 2 in order to increase controlled patients and 
decrease the incidence of complications due to the disease.
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Objectives: Adherence to treatment plan and lifestyle advice is crucial for good 
health outcomes in diabetic patients. Given that Greece in the last years faces an 
unprecedented economic crisis which affects all sectors of economic and social life, 
the aim of the present study was to examine whether recession, austerity measures 
and implemented health policies had an impact on patient adherence to treatment 
in Diabetes type 2 (dt2) in Greece. MethOds: A questionnaire was developed for 
the purpose of the study. Only Physicians who monitor patients with dt2 (general 
practitioners (GPs), diabetologists and endocrinologists) were invited to participate in 
the study and complete the online version of a purpose-made questionnaire during a 
specified time period. Physicians were recruited through their national associations. 
The study took place between April and May 2014. Results: Of the 176 physicians 
completing the questionnaire, 68.7% were men. Mean age was 47.8 years. The majority 
were internists (38.3%) and GPs (32,7%). Physicians estimated that during the previ-
ous year 22.9% of their patients had to quit or modify their treatment plan due to 
economic reasons. A somewhat higher percentage (26.9%) was found regarding the 
modification of the dietary habits during the previous year due to economic reasons 
which led to negative health outcomes. According to the participating physicians the 
main reasons for which patients modified or quitted their treatment were the higher 
copayments for pharmaceuticals, loss of insurance coverage and barriers of access 
to a physician in order to prescribe their medicines. cOnclusiOns: Recession and 
recent health policies had a negative impact on patients’ adherence to treatment 
leading to poor adherence almost a quarter of patients with dt2, based on the expe-
rience of physicians. Equally critical is the fact that patients were forced to modify 
their dietary habits.
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2 diabetes. MethOds: This was a retrospective cohort study that identified the DD 
adults with type 2 diabetes from the MarketScan® Multi-State Medicaid Database. 
Enrollees aged 18-64 years who received new anti-diabetic medications from January 1, 
2004 and December 31, 2006 were included. An index diagnosis date was assigned to 
each patient and adults with a continuous enrollment for at least 12 months were 
included. Multivariate negative binomial regression was used to measure the rate of 
change in type 2 diabetes related health care utilization (inpatient, outpatient and 
emergency department visits) in DD patients. Multivariate linear regression with log-
transformation was used to determine type 2 diabetes related health care costs in DD 
Medicaid enrollees. Results: The study population comprised of 1529 patients. After 
controlling for all the covariates, compared to DD Caucasians, DD African Americans 
were more likely to have type diabetes related inpatient (OR= 1.71; 95% CI, 1.02-2.85) 
and emergency department visits (OR, 1.67; 95% CI, 1.02-2.73). After holding all the 
other covariates constant, among DD patients with type 2 diabetes, compared to 
Caucasians, African American patients had 23% significantly higher medication 
costs, 26% significantly higher medical costs and 21% significantly higher overall 
costs respectively. cOnclusiOns: Racial disparities exist in health care utilization in 
DD Medicaid patients with type 2 diabetes. Access to culturally competent health care 
providers, providers who accept Medicaid patients and continuous care can reduce 
inpatient visits and emergency room visits in racial minorities.
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Hypoglycemia (Hypo) is a common adverse effect of type 2 diabetes (T2D) therapy. 
Oral antidiabetic (OAD) agents differ in their propensity to cause Hypo. Hypo has 
a negative impact on health care resources and quality of life (QoL) and can affect 
compliance and T2D control. Objectives: To estimate the impact of different 
OADs on Hypo prevalence and on the QoL of T2D patients in Greece. MethOds: 
A cross-sectional epidemiological study was conducted in 6631 patients with T2D. 
Hypo events with different treatment regimens, T2D control rates and QoL were 
assessed. Hypo episodes were defined as laboratory-confirmed (< 70 mg/dl) symp-
tomatic events. QoL was measured using the patient-administered ADDQoL-19 
questionnaire. Diabetes control was defined as Hb1Ac ≤ 7%. Results: Mean age 
was 60 and mean T2D duration 10 years. 59% of patients had HbA1c > 7%; 20.4% had 
Hypo. Most patients (82%) were on combination therapies, while 14.5% were on oral 
monotherapy and the remaining were on insulin or GLP-1 analog treatment. The 
overall QoL in the three OAD monotherapy groups [biguanides, DPP4is and sulfony-
lureas (SUs)] were not statistically significant between groups, regardless of Hypo 
status. However, patients treated with biguanide or DPP4i monotherapy had lower 
rates of Hypo vs. patients on SU monotherapy (p≤ 0.001) and QoL in Hypo patients 
treated with biguanides or DPP-4is was better compared to SUs (p< 0.001). Similarly, 
more patients on biguanides and DPP4i monotherapies achieved HbA1c ≤ 7% than 
on SU (p≤ 0.001). Patients receiving combinations of biguanides with DPP4is vs. 
biguanides with SUs had significantly less Hypo (p≤ 0.001), better diabetes control 
(respectively; p≤ 0.001) and better QoL (p≤ 0.05). cOnclusiOns: Biguanides, DPP4is 
and their combinations are associated with lower rates of Hypo, better QoL and 
T2D control, compared with SUs alone or in combination with biguanides. In T2D, 
treatment should attain good glycemic control without debilitating hypoglycemic 
episodes, which compromise patients’ QoL.
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Objectives: Comparison of the changes in QoL of diabetic patients after phar-
maceutical cognitive service with SF-6D. MethOds: Tree step methodology was 
created and applied towards the patients with type 1 and type 2 diabetes. On first 
the QoL of 146 diabetic patients was assessed with the Bulgarian version of SF-6D. 
Then educational program for the diabetic patients was developed and applied 
during the day of their visits in community pharmacy from June to September 2013. 
At the end the changes in the QoL after the pharmaceutical cognitive service was 
assessed in the group of 24 patients. Results: The mean age of patients included 
in the first step was 57.39 years (SD 17.087; 95%CI 54.60-60.19). 76% of them were 
with type 2 diabetes and 73% suffers from diabetes complications. The mean SF-6D 
score was 0.629 (SD 0.289; 95%CI 0.58-0.68). After the pharmacy program the type 
2 diabetic patients showed better quality of life index 0.7133 that was 10% higher 
than the initial score 0.6089. In the patients with type 1 diabetes the improvement of 
QoL score is with 3 %. The patients were with mean SF-6D scores: 0.667 on the first 
visit in the pharmacy and 0.690 after the educational service. cOnclusiOns: The 
study suggests the SF-6D is a valuable tool for QoL assessment of diabetes patients 
in Bulgaria. It also shows that SF-6D could be used for pharmacy program evalua-
tion in diabetes patients. Regarding the pharmaceutical cognitive service in diabetic 
patients is evident that they have a potential to improve the QoL in patients with 
diabetes mellitus and their impact could be measured with SF-6D.
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